HORNBILL: A First-in-Human Phase I/IIa Study of the Safety, Tolerability and Early Pharmacodynamics of BI 764524 for Diabetic Macular Ischemia
DOI:
10.1016/j.xops.2025.100781
Publication Date:
2025-04-01T09:45:34Z
AUTHORS (12)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (26)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....